Amylyx Pharmaceuticals

Cambridge, United States

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Sep 2025

Post-IPO Equity

Biotechnology Medical Neuroscience Pharmaceutical

Top Investors

Alpha Wave GlobalPerceptive AdvisorsBain Capital Life SciencesRock Springs CapitalViking Global Investors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amylyx Pharmaceuticals

Who are Amylyx Pharmaceuticals's investors?

Amylyx Pharmaceuticals's investors include Alpha Wave Global, Perceptive Advisors, Bain Capital Life Sciences, Rock Springs Capital, Viking Global Investors.

Where is Amylyx Pharmaceuticals headquartered?

Amylyx Pharmaceuticals is headquartered in Cambridge, United States.

What does Amylyx Pharmaceuticals do?

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

What stage is Amylyx Pharmaceuticals at?

Amylyx Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 10, 2025.

MLA

"Amylyx Pharmaceuticals — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/amylyx-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2025). Amylyx Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/amylyx-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Amylyx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/amylyx-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 10, 2025.